STERIS plc $STE Stock Holdings Lifted by Handelsbanken Fonder AB

Handelsbanken Fonder AB lifted its position in STERIS plc (NYSE:STE) by 15.4% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 74,445 shares of the medical equipment provider’s stock after acquiring an additional 9,935 shares during the quarter. Handelsbanken Fonder AB’s holdings in STERIS were worth $18,873,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in STE. Nordea Investment Management AB grew its holdings in shares of STERIS by 259.0% during the fourth quarter. Nordea Investment Management AB now owns 51,602 shares of the medical equipment provider’s stock valued at $13,165,000 after buying an additional 37,228 shares in the last quarter. Dimensional Fund Advisors LP lifted its stake in STERIS by 9.4% in the 3rd quarter. Dimensional Fund Advisors LP now owns 1,039,351 shares of the medical equipment provider’s stock worth $257,157,000 after acquiring an additional 89,250 shares in the last quarter. Legal & General Group Plc boosted its position in STERIS by 5.3% during the 3rd quarter. Legal & General Group Plc now owns 693,116 shares of the medical equipment provider’s stock worth $171,505,000 after acquiring an additional 34,981 shares during the period. Groupama Asset Managment acquired a new stake in STERIS during the 3rd quarter worth about $1,163,000. Finally, Elo Mutual Pension Insurance Co purchased a new position in STERIS during the 3rd quarter valued at about $2,480,000. Institutional investors and hedge funds own 94.69% of the company’s stock.

STERIS Stock Up 0.5%

STE opened at $215.51 on Thursday. The company has a market capitalization of $21.14 billion, a PE ratio of 27.18 and a beta of 0.95. The company has a debt-to-equity ratio of 0.25, a current ratio of 2.09 and a quick ratio of 1.54. STERIS plc has a fifty-two week low of $195.14 and a fifty-two week high of $269.44. The business has a 50-day moving average of $218.56 and a 200-day moving average of $242.42.

STERIS (NYSE:STE) last announced its quarterly earnings results on Monday, May 11th. The medical equipment provider reported $2.83 EPS for the quarter, missing the consensus estimate of $2.86 by ($0.03). STERIS had a net margin of 13.18% and a return on equity of 14.15%. The firm had revenue of $1.59 billion during the quarter, compared to the consensus estimate of $1.59 billion. During the same period in the previous year, the firm posted $2.74 EPS. The company’s quarterly revenue was up 6.7% compared to the same quarter last year. STERIS has set its FY 2027 guidance at 11.100-11.300 EPS. Equities research analysts forecast that STERIS plc will post 11.18 EPS for the current fiscal year.

STERIS Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, June 26th. Stockholders of record on Monday, June 8th will be paid a dividend of $0.63 per share. The ex-dividend date is Monday, June 8th. This represents a $2.52 annualized dividend and a dividend yield of 1.2%. STERIS’s dividend payout ratio is 31.78%.

Analyst Ratings Changes

A number of analysts have recently issued reports on STE shares. KeyCorp reduced their price target on shares of STERIS from $291.00 to $269.00 and set an “overweight” rating for the company in a research report on Wednesday, May 13th. Weiss Ratings lowered shares of STERIS from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Thursday, April 16th. Finally, Wall Street Zen upgraded shares of STERIS from a “buy” rating to a “strong-buy” rating in a research report on Saturday, May 16th. Two analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, STERIS has an average rating of “Moderate Buy” and an average price target of $275.67.

Insider Buying and Selling at STERIS

In other news, Director Cynthia L. Feldmann sold 3,098 shares of the firm’s stock in a transaction on Thursday, March 5th. The shares were sold at an average price of $237.21, for a total transaction of $734,876.58. Following the transaction, the director owned 705 shares in the company, valued at approximately $167,233.05. This trade represents a 81.46% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 1.07% of the company’s stock.

About STERIS

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.